Mapping of ligand binding sites of neuronal nicotinic acetylcholine receptors using chimeric alpha subunits

CW Luetje, M Piattoni and J Patrick

Division of Neuroscience, Baylor College of Medicine, Houston, Texas 77030.

We constructed a series of chimeric neuronal nicotinic acetylcholine (ACh) receptor (nAChR) alpha subunits to map the location of amino acid residues that determine the pharmacological properties of these receptors. The alpha 2 and alpha 3 subunits form pharmacologically distinct nAChRs upon expression, in combination with the beta 2 subunit, in Xenopus oocytes. The alpha 2 beta 2 subunit combination is insensitive to the nicotinic antagonist neuronal bungarotoxin (NBT) and is much more sensitive to nicotine than to ACh. In contrast, the alpha 3 beta 2 subunit combination is potently inhibited by NBT and is much less sensitive to nicotine than to ACh. Chimeric subunits were constructed by replacing portions of alpha 2 or alpha 3 with the analogous portion of the other alpha subunit. Pharmacological analysis of receptors formed by these chimeric subunits, in combination with beta 2, revealed that amino acid residues involved in determining NBT sensitivity were located within sequence segments 84-121, 121-181, and 195-215. Amino acid residues that determine agonist sensitivity were located within sequence segments 1-84 and 195-215. Within region 195- 215, we used site-directed mutagenesis to demonstrate the importance of Gln-198 of alpha 3 (proline in alpha 2) in determining both the antagonist sensitivity and the agonist sensitivity of neuronal nAChRs.

Volume 44, Issue 3, pp. 657-666, 09/01/1993
Copyright © 1993 by American Society for Pharmacology and Experimental Therapeutics

This article has been cited by other articles:

				D. Everhart, E. Reiller, A. Mirzoian, J. M. McIntosh, A. Malhotra, and C. W. Luetje Identification of Residues That Confer {alpha}-Conotoxin-PnIA Sensitivity on the {alpha}3 Subunit of Neuronal Nicotinic Acetylcholine Receptors J. Pharmacol. Exp. Ther., August 1, 2003; 306(2): 664 - 670. [Abstract] [Full Text] [PDF]

				P. Dobelis, M. J. Marks, P. Whiteaker, S. A. Balogh, A. C. Collins, and J. A. Stitzel A Polymorphism in the Mouse Neuronal alpha 4 Nicotinic Receptor Subunit Results in An Alteration in Receptor Function Mol. Pharmacol., August 1, 2002; 62(2): 334 - 342. [Abstract] [Full Text] [PDF]

				L. H. Wilkins Jr., A. Haubner, J. T. Ayers, P. A. Crooks, and L. P. Dwoskin N-n-Alkylnicotinium Analogs, A Novel Class of Nicotinic Receptor Antagonist: Inhibition of S(-)-Nicotine-Evoked [3H]Dopamine Overflow from Superfused Rat Striatal Slices J. Pharmacol. Exp. Ther., June 1, 2002; 301(3): 1088 - 1096. [Abstract] [Full Text] [PDF]

				M. J. Parker, S. C. Harvey, and C. W. Luetje Determinants of Agonist Binding Affinity on Neuronal Nicotinic Receptor beta Subunits J. Pharmacol. Exp. Ther., October 1, 2001; 299(1): 385 - 391. [Abstract] [Full Text] [PDF]

				M. M. Levandoski, Y. Lin, L. Moise, J. T. McLaughlin, E. Cooper, and E. Hawrot Chimeric Analysis of a Neuronal Nicotinic Acetylcholine Receptor Reveals Amino Acids Conferring Sensitivity to alpha -Bungarotoxin J. Biol. Chem., September 10, 1999; 274(37): 26113 - 26119. [Abstract] [Full Text] [PDF]

				R. W. Vazquez and R. E. Oswald Identification of a New Amino Acid Residue Capable of Modulating Agonist Efficacy at the Homomeric Nicotinic Acetylcholine Receptor, alpha 7 Mol. Pharmacol., January 1, 1999; 55(1): 1 - 7. [Abstract] [Full Text]

				C. W. Luetje, F. N. Maddox, and S. C. Harvey Glycosylation within the Cysteine Loop and Six Residues Near Conserved Cys192/Cys193 Are Determinants of Neuronal Bungarotoxin Sensitivity on the Neuronal Nicotinic Receptor alpha 3 Subunit Mol. Pharmacol., June 1, 1998; 53(6): 1112 - 1119. [Abstract] [Full Text]

				P.-J. Corringer, S. Bertrand, S. Bohler, S. J. Edelstein, J.-P. Changeux, and D. Bertrand Critical Elements Determining Diversity in Agonist Binding and Desensitization of Neuronal Nicotinic Acetylcholine Receptors J. Neurosci., January 15, 1998; 18(2): 648 - 657. [Abstract] [Full Text] [PDF]

				S. R. Grady, E. U. Grun, M. J. Marks, and A. C. Collins Pharmacological Comparison of Transient and Persistent [3H]Dopamine Release from Mouse Striatal Synaptosomes and Response to Chronic L-Nicotine Treatment J. Pharmacol. Exp. Ther., July 1, 1997; 282(1): 32 - 43. [Abstract] [Full Text]

				S. C. Harvey, J. M. Mcintosh, G. E. Cartier, F. N. Maddox, and C. W. Luetje Determinants of Specificity for alpha -Conotoxin MII on alpha 3beta 2 Neuronal Nicotinic Receptors Mol. Pharmacol., February 1, 1997; 51(2): 336 - 342. [Abstract] [Full Text] [PDF]

				S. C. Harvey and C. W. Luetje Determinants of Competitive Antagonist Sensitivity on Neuronal Nicotinic Receptor beta  Subunits J. Neurosci., June 15, 1996; 16(12): 3798 - 3806. [Abstract] [Full Text] [PDF]